Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Randomized Trial of Fixed-Dose Capecitabine Compared With Standard-Dose Capecitabine in Metastatic Breast Cancer: X-7/7 Trial.
Journal: JCO oncology advances
Published: September 09, 2024
Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer.
Journal: NPJ breast cancer
Published: February 17, 2022
Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I-III Triple-negative Breast Cancer (NeoSTOP).
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 15, 2020
Pegylated liposomal doxorubicin plus carboplatin in patients with metastatic breast cancer: a phase II study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 21, 2012
Showing 1-4 of 4
Last Updated: 09/26/2026